Novavax Inc. (NVAX) Launches $5 Million Production Facility to Drive Vaccine Production
Novavax Inc. (Nasdaq: NVAX) today joined the State of Maryland and Montgomery County in celebration of the opening of the company’s new $5 million vaccine production facility at the company's headquarters in Rockville, Md. The 5,000 square-foot plant will be used to produce vaccines using the company’s virus-like particle (VLP) technology, which will combat a broad range of infectious diseases. The facility has the capacity to supply 10 million doses of the influenza vaccine for the company's current clinical programs. According to the press release, the facility marks a “major milestone” for the company’s development team. “This facility is seen…